Abstract:SUMOylation is a highly dynamic post-translational modification which regulates protein function and/or stability. It involves conjugation of SUMOs ( S mall U biquitin-Like Mo difier s ) to the lysine residue/s of target proteins mediated via a highly coordinated enzymatic mechanism. Studies have shown that promoting SUMOylation (SUMO2/3) causes vascular endothelial dysfunction and accelerates atherosclerosis. We reported that SUMO2 overexpression in endothelial cells promotes oxidative stress and impairs endothelial function. However, the mechanism is not well understood. Adaptor protein p66Shc is a master regulator of oxidative stress and endothelial function. Genetic deletion of p66Shc protects mice against endothelial dysfunction due to metabolic dysregulation. Prior studies have shown that lysine modification of p66Shc regulates its oxidative function. As SUMOylation primarily occurs on lysine residue, we examined if p66Shc is a target of SUMO2. In this study, we show that p66Shc is a direct target of SUMO2. Using endothelial cells and HEK-293 cells, we show that overexpression of SUMO2 leads to p66Shc SUMO2ylation which is further increased in presence of E2-ligase Ubc9 and reduced by deSUMOylating enzyme SENP1. SUMO2ylation of p66Shc increases oxidative activation (serine-36 phosphorylation) of p66Shc which is essential for reactive oxygen production by p66Shc. Using mass spectroscopic study, we identified that lysine-81 is the only lysine present in CH2 domain which is getting SUMO2ylated. Rendering p66ShcK81 non-sumoylatable (p66ShcK81R) prevented the SUMO2ylation of p66Shc. In endothelial cells, overexpression of p66ShcK81R prevented the SUMO2-induced increase in serine-36 phosphorylation and mitochondrial translocation of p66Shc, which are essential for oxidative function of p66Shc. Collectively, we present a novel molecular mechanism via which SUMO2 regulates the oxidative function of p66Shc and identify a unique post-translational regulation of p66Shc in endothelial cells.

p66Shc in Cardiovascular Pathology

p66Shc links alpha1-adrenergic receptors to a reactive oxygen species-dependent AKT-FOXO3A phosphorylation pathway in cardiomyocytes

p66Shc Contributes to Liver Fibrosis through the Regulation of Mitochondrial Reactive Oxygen Species

p66Shc Adapter Protein and Its Implications for Metabolic Disorders

p66Shc Protein—Oxidative Stress Sensor or Redox Enzyme: Its Potential Role in Mitochondrial Metabolism of Human Breast Cancer

Inhibition of p66ShcA redox activity in cardiac muscle cells attenuates hyperglycemia-induced oxidative stress and apoptosis

Distribution of the p66Shc Adaptor Protein Among Mitochondrial and Mitochondria—Associated Membranes Fractions in Normal and Oxidative Stress Conditions

The interplay between p66Shc, reactive oxygen species and cancer cell metabolism

P66Shc Mediates SUMO2-induced Endothelial Dysfunction

Advancement of regulation of p66Shc expression and its role in diabetic nephropathy

P66shc Mediates High-Glucose and Angiotensin II-induced Oxidative Stress Renal Tubular Injury Via Mitochondrial-Dependent Apoptotic Pathway.

p66Shc Aging Protein in Control of Fibroblasts Cell Fate

Abstract 14657: p66Shc Mediates SUMO2-Induced Endothelial Dysfunction and ROS Production

Dual Role of Endothelial Nitric Oxide Synthase in Oxidized LDL-Induced, p66Shc-Mediated Oxidative Stress in Cultured Human Endothelial Cells

USP15 Regulates P66shc Stability Associated with Drp1 Activation in Liver Ischemia/reperfusion

Role of adaptor protein p66Shc in diabetes and its complication

Abstract 214: Sumo2 Regulates Oxidative Function Of Adaptor Protein P66shc

Cathepsin L Deficiency Results in Reactive Oxygen Species (ROS) Accumulation and Vascular Cells Activation

BAG3 Mediated Down-regulation in Expression of p66shc has Ramifications on Cellular Proliferation, Apoptosis and Metastasis

The Role of p66Shc in Diabetes: A Comprehensive Review from Bench to Bedside

P66shc Promotes HCC Progression in the Tumor Microenvironment Via STAT3 Signaling